Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02752178 : Peripheral Immunomarker Validation in Treatment-resistant Depression
PhaseN/A
AgesMin: 25 Years Max: 50 Years
Eligibility
Inclusion Criteria:

- Major depressive disorder diagnosed by structured clinical interview in accordance
with Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria

- Aged 25-50 years inclusive

- HAM-D score at baseline

1. DEP+MA+ subgroup > 13

2. DEP+MA- subgroup > 17

3. DEP-MA+ subgroup < 7

- Able and willing to give informed consent, including consent to sharing of clinical
information with the participant's general practitioner

- Willing to abstain from strenuous exercise for 72 hours prior to assessment

- Able to write, speak and understand English

Exclusion Criteria:

- Life time history of bipolar disorder or nonaffective psychosis

- Concurrent medication likely to compromise the interpretation of immunological data
(including, but not limited to corticosteroids, or any other substance to be
determined by the Principal Investigator or delegate)

- Pregnancy or breast feeding

- Active alcohol or drug abuse or dependence in the last 6 months

- Participation in clinical trial of an investigational drug within the last 12 months

- Lifetime history of any serious medical disorder likely to compromise the
interpretation of immunological data (including, but not limited to, immunological
disorders, cardiovascular disorders, malignancies or infection, or any other
condition to be determined by the Principal Investigator or delegate)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02752178      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740